Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR - or ALK -Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
- Sehhoon Park
- , Tae Min Kim
- , Ji Youn Han
- , Gyeong Won Lee
- , Byoung Yong Shim
- , Yun Gyoo Lee
- , Sang We Kim
- , Il Hwan Kim
- , Suee Lee
- , Yu Jung Kim
- , Ji Hyun Park
- , Sang Gon Park
- , Ki Hyeong Lee
- , Eun Joo Kang
- , Ju Won Kim
- , Seong Hoon Shin
- , Chan Young Ock
- , Byung Ho Nam
- , Jaebong Lee
- , Hyun Ae Jung
- Seoul National University
- National Cancer Center Korea
- Gyeongsang National University
- The Catholic University of Korea
- Kangbuk Samsung Hospital
- University of Ulsan
- Inje University
- Dong-A University
- Konkuk University
- Chosun University
- Chungbuk National University
- Korea University
- Kosin University
- Lunit, Inc.
- HERINGS
- Seoul
Research output: Contribution to journal › Article › peer-review
189
Link opens in a new tab
Scopus
citations